Next Generation Diagnosis

The industry is witnessing significant disruptions around new regulations (PAMA implementation, deployment of laboratory developed tests) and move towards decentralized testing (home & retail type settings). Laboratory managers, ACOs and corporate executives need actionable insights to mitigate these disruptions and discover new growth opportunities in Point of Care Testing, Molecular Diagnostics, Laboratory Automation, and Smart Genomics markets.

advanced medical technology

Frost & Sullivan’s Next Generation Diagnosis Research Program

Next Generation Diagnosis program provides a truly end-to-end perspective analysis of ‘white space’ opportunities across IVD and Genomics markets.  It enables companies to stay ahead of the shift to Direct to Consumer testing, track investments in Biomarkers (companion diagnostics) and adapt new business models in Clinical Laboratory services and Lab Automation markets. The team offers expert coverage on a variety of issues including profitable growth opportunities and partnerships with start-ups to strengthen position in the emerging data-driven ecosystem.

Frost & Sullivan’s expertise in Next Generation Diagnosis research and consulting includes work in the following strategic and operational areas:

Molecular Diagnostics icon

Molecular Diagnostics & Companion Diagnostics

High convergence of molecular diagnostics and big data analytics will enable predictive analytical capabilities for diagnostic platforms.  Several in vitro diagnostic (IVD) companies are expanding their product portfolios to include liquid biopsy and companion diagnostics (CDx) in their long-term strategies. Our research coverage includes tissue diagnostics, liquid biopsy, digital pathology and pre-natal diagnostics and biomarkers for combination therapies.

Business Process Healthcare

Point Of Care Testing (POCT) & Smart Genomics

New business models such as expansion into retail clinics, mobile clinics, and patient self-testing platforms (apps) have opened up several new opportunities for POCT companies. Suppliers are pushed to innovate on product capabilities (accuracy) and connectivity (communication with EMR, LIS systems). Research labs have jump-started spending on cloud, NGS and big data analytics solutions. Our research coverage includes infectious disease diagnostics, cardiac biomarkers, in vitro fertilization (IVF) services, and direct to consumer testing.

Laboratory Automation Icon

Laboratory Automation

Adoption of digital workflow management practices and automated solutions is a key growth driver for labs to improve their efficiency and reduce cost. Over the last 10 years, the industry has witnessed a large number of M&A activities, as large companies were looking to aggressively expand their product portfolio and customer base. Genomics solutions are expected to witness higher growth than proteomics. Our research coverage includes clinical lab services, aftermarket functional consumables, and future of smart labs.


Book a complimentary one-hour Growth Pipeline Dialog™ session with our Healthcare & Life Sciences experts.

Greg Caressi

Greg Caressi has served in executive management roles, building and leading market analytics, growth advisory, and sales and business development teams. In addition to authoring numerous studies in his areas of focus, he has been involved in numerous strategic growth projects, with a focus on:

  • Next-generation technologies and technology adoption.
  • End-user and product/feature/pricing analysis.
  • International expansion strategies.
  • Competitive analysis.
  • M&A target analysis.
  • Detailed demand modeling.
  • Next-generation healthcare, with a focus on digital health, telehealth, data and analytics, and customer engagement solutions.
  • Healthcare and life science information technology.
  • Health IT infrastructure and platforms.

Greg has hands-on experience in international expansion strategies and implementation in Asia and Latin America and on-the-ground experience in China, Brazil, Mexico, Argentina, Colombia, and other developing economies. He has been a chairman, speaker, and trainer at industry conferences and events in the U.S., Asia, and Latin America.

Reenita Das

Reenita Das is a healthcare futurist and strategist, passionate about changing the healthcare industry. She was voted among the top 100 women in Femtech and Healthtech and the top 50 Healthcare strategists to follow in 2021. She has lived and worked in over 10 countries, focusing on healthcare issues and working with the public and private sectors to implement growth change strategies. She serves as Partner and Senior Vice President and is the first woman Partner at Frost & Sullivan.

Her areas of interest in identifying growth opportunities include:

  • Women’s health.
  • Digital health.
  • Precision diagnostics and precision medicine.
  • Chronic disease management.

Dinesh Sampath Rangaraj

Dinesh is passionate about building organizations and helping them grow. He has over 20 years of experience advising clients across healthcare, semiconductors, and information, communication, and technology sectors. As Senior Vice President and Principal, Dinesh works as a trusted advisor to senior leadership at companies to drive growth and be ready for the future. His areas of expertise include:

  • Business strategy.
  • M&A and partnerships.
  • Business model transformation.
  • Sales and marketing strategy.
  • Product portfolio strategy.
Vice President, Growth Opportunity Analytics, Global Practice Area Leader - Healthcare & Life Sciences

Nitin Naik

With more than 24 years of industry experience, Nitin serves as Frost & Sullivan’s Global Practice Area Leader (HLS). In this role, he is dedicated to executing strategy consulting, forecasting analytics, commercial due diligence and clinical R&D projects for healthcare companies.

Nitin has a strong understanding of the dynamics in the healthcare industry and possesses domain knowledge in the life sciences space. He has advised several mid sized companies and start-ups in numerous commercial transactions and IPOs to optimize market positioning and valuation strategies.

He has led strategic initiatives with Medical Device & Life Science companies:

  • Emerging markets go to market strategy , Innovative therapies portfolio analysis
  • Sales, Marketing, Distribution planning
  • Global Alliances, Public Private Partnerships, M&A.
  • Co-innovation programs, research
Sr Vice President, Growth Pipeline Advisory and Delivery Global Practice Area Leader - Healthcare & Life Sciences

Sujith Eramangalath

Vice President, Growth Pipeline Advisory and Delivery, Americas - Healthcare & Life Sciences

Charlie Whelan

Charlie leads Frost & Sullivan’s growth consulting practice in the Americas supporting clients across the healthcare technology and services ecosystem. His responsibilities include project management, business development, strategic planning and subject matter expertise, particularly in the medical devices market.

Vice President, Growth Pipeline Advisory and Delivery, Europe - Healthcare & Life Sciences

Siddharth Saha

Vice President, Growth Pipeline Advisory and Delivery, Asia Pacific - Healthcare & Life Sciences

Milind Sabnis

Consulting Director, South Asia

Sowmya Srinath

Research Manager, Healthcare & Life Sciences

Siddharth Shah

Siddharth (Sid) Shah leads the global medtech research program of the Healthcare & Life Sciences practice, and has over ten years of healthcare market research & consulting experience. In his prior life he has also conducted wet lab research in stem cells at the prestigious Johns Hopkins University. Beyond medical devices, Shah also tracks innovations in radiology artificial intelligence, diabetes, and connected devices. He holds a Master of Science in Biotechnology from the Johns Hopkins University.

Unmesh Lal

Unmesh Lal has 20+ years of healthcare industry with expertise, primarily comprising of strategy advisory with global life sciences companies. His expertise lies in tracking game-changing companies, innovative business models and disruptive technologies while serving as a growth coach to clients in their precision health journey. He has authored thought leadership and presented at leading industry events like J.P.Morgan, BIO-Asia, CPHI World, Bio-IT, Medica Health IT, Medtec, Precision Medicine Exhibition & Summit, Basel Life, to name a few. His in-depth understanding of the precision health ecosystem enables him to guide companies in identifying growth opportunities across precision screening and diagnosis, personalized therapeutics, surveillance & monitoring, and discovery & development solutions/service. He holds a master’s degree in biomedical engineering from the University of Michigan – Ann Arbor.

As a Growth Opportunity Analytics Director of Frost & Sullivan’s Healthcare & Life Sciences practice, Unmesh’s interests and areas of expertise include:

  • Pharma & Biotech (Targeted Therapeutics, Contract Discovery, Development & Manufacturing)
  • Digital Transformation (Life Sciences IT- Smart R&D, Flexible Mfg., Connected Patients)
Consulting Director, Life Sciences

Christi Bird

Consulting Director, Digital Health, Medical Imaging & Informatics

Daniel Ruppar

Consulting Director, Europe & Israel

Paljit Sohal

Senior Director, Growth Pipeline Advisory and Delivery, Asia Pacific - Healthcare & Life Sciences

Kiranjit Kaur

Consulting Director, Asia Pacific

Rathanesh Ramasundram

Consulting Leader, Growth Pipeline Advisory & Delivery, Middle East & Africa

Daniel I’Anson

Daniel leads the growth consulting practice for Healthcare & Life Sciences in the Middle East & Africa. This practice covers Healthcare Delivery & Operations, Medical Imaging & Informatics, Pharmaceuticals & Life Sciences, and Digital Health.

Daniel is a seasoned healthcare professional with more than 15 years’ experience in the healthcare industry and has extensive experience supporting clients to achieve their strategic growth objectives through Optimization, Efficiency, Quality and Cost Initiatives; Market Analysis, Customer VOC/Perception studies, Due Diligence, and Service Expansion; Healthcare Data and Analytics; Change, Program and Project Management; and, Leadership Development.

Senior Industry Analyst, Medical Imaging & Informatics

Imran Khan

Imran has over 20 years of experience in market research and consulting, covering a range of information and communication technologies across multiple industry verticals and enterprise and consumer segments.

Industry Principal, Digital Health

Victor Camlek

Industry Principal, Digital Health

Koustav Chatterjee

Senior Industry Analyst, Digital Health

Chandni Mathur

Industry Principal, Americas

Patrick Riley

Value Proposition

The Clinical Diagnostics & Research Tools team utilizes a proven methodology that leverages Frost & Sullivan’s proprietary forecast models, access to high-quality internal and external published content, and information gained from primary research interviews. The team provides the content that goes well beyond the basic news that everyone can access.